Alumis (ALMS) Gains from Investment Securities (2023 - 2025)
Alumis (ALMS) reported Gains from Investment Securities of $3.8 million for Q4 2025, down 46.17% quarter-over-quarter from $7.0 million in Q3 2025.
Alumis (ALMS) Gains from Investment Securities (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Gains from Investment Securities data on file, last reported at $3.8 million in Q4 2025.
- Gains from Investment Securities for Q4 2025 came in at $3.8 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $3.4 million (changed N/A YoY), and the FY2025 annual result was $18.7 million, up 944.4% from the prior year.
- Gains from Investment Securities slipped to $3.8 million in Q4 2025 per ALMS's latest filing, from $7.0 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $14.2 million in Q3 2023 and troughed at -$14.5 million in Q4 2023.
- A 3-year average of $3.8 million and a median of $4.3 million in 2025 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2024 and 2025: Gains from Investment Securities plunged 98.34% in 2024, then jumped 2867.7% in 2025.
- A 3-year view of Gains from Investment Securities shows it stood at -$14.5 million in 2023, then surged by 101.62% to $235304.0 in 2024, then surged by 1497.51% to $3.8 million in 2025.
- Business Quant data shows ALMS's Gains from Investment Securities at $3.8 million in Q4 2025, $7.0 million in Q3 2025, and $4.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Alumis | 1.99 Bn | 1.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.76 Mn |
| Dec 31, 2025 | 3.76 Mn |
| Sep 30, 2025 | 6.98 Mn |
| Sep 30, 2025 | 6.98 Mn |
| Jun 30, 2025 | 4.27 Mn |
| Jun 30, 2025 | 4.27 Mn |
| Mar 31, 2025 | 11.46 Mn |
| Mar 31, 2025 | 11.46 Mn |
| Sep 30, 2024 | 235,304.00 |
| Sep 30, 2024 | 235,304.00 |
| Dec 31, 2023 | -14.52 Mn |
| Dec 31, 2023 | -14.52 Mn |
| Sep 30, 2023 | 14.16 Mn |
| Sep 30, 2023 | 14.16 Mn |